RBC Life Sciences, Inc. (RBCL)

RBC Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Revenue	24.12	28.27	25.47	25.16	28.45	28.16
Revenue Growth (YoY)	-12.49%	10.99%	1.23%	-11.56%	1.03%	12.97%
Cost of Revenue	10.39	12.63	13.46	12.53	14.13	14.47
Gross Profit	13.72	15.64	12.01	12.63	14.32	13.69
Selling, General & Admin	15.59	15.76	12.13	13.02	13.95	12.17
Operating Expenses	16.04	16.26	12.64	13.54	14.39	12.64
Operating Income	-2.32	-0.63	-0.62	-0.91	-0.07	1.04
Interest Expense	-0.06	-0.1	-0.11	-0.13	-0.14	-0.15
EBT Excluding Unusual Items	-2.38	-0.72	-0.74	-1.03	-0.21	0.89
Pretax Income	-0.67	-0.72	-0.74	-0.59	-0.21	0.89
Income Tax Expense	-0.11	-0.12	-0.24	-0.23	-0.14	0.33
Net Income	-0.56	-0.6	-0.5	-0.36	-0.07	0.56
Net Income to Common	-0.56	-0.6	-0.5	-0.36	-0.07	0.56
Shares Outstanding (Basic)	2	2	2	2	2	2
Shares Outstanding (Diluted)	2	2	2	2	2	2
Shares Change (YoY)	0.00%	-0.29%	-0.19%	-	-0.92%	2.35%
EPS (Basic)	-0.25	-0.27	-0.23	-0.16	-0.03	0.25
EPS (Diluted)	-0.25	-0.27	-0.23	-0.16	-0.03	0.20
Free Cash Flow	-3.29	-1.68	0.03	-0.36	-0.23	0.38
Free Cash Flow Per Share	-1.49	-0.76	0.01	-0.16	-0.10	0.17
Gross Margin	56.90%	55.32%	47.16%	50.21%	50.32%	48.60%
Operating Margin	-9.60%	-2.21%	-2.45%	-3.60%	-0.25%	3.71%
Profit Margin	-2.32%	-2.13%	-1.96%	-1.44%	-0.25%	1.98%
Free Cash Flow Margin	-13.63%	-5.95%	0.11%	-1.43%	-0.79%	1.35%
EBITDA	-1.79	-0.05	-0.04	-0.32	0.44	1.58
EBITDA Margin	-7.44%	-0.16%	-0.14%	-1.28%	1.53%	5.62%
D&A For EBITDA	0.52	0.58	0.59	0.58	0.51	0.54
EBIT	-2.32	-0.63	-0.62	-0.91	-0.07	1.04
EBIT Margin	-9.60%	-2.21%	-2.45%	-3.60%	-0.25%	3.71%
Effective Tax Rate	-	-	-	-	-	37.42%
Advertising Expenses	-	0.04	0.04	0.12	0.06	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.